Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Monday's After-Market Session

Author: Benzinga Insights | August 04, 2025 05:07pm

Gainers

  • Adaptimmune Therapeutics (NASDAQ:ADAP) stock moved upwards by 26.1% to $0.1 during Monday's after-market session. The company's market cap stands at $21.1 million.
  • Castle Biosciences (NASDAQ:CSTL) stock rose 14.16% to $17.49. The company's market cap stands at $422.5 million. As per the press release, Q2 earnings came out today.
  • Ardelyx (NASDAQ:ARDX) stock rose 13.21% to $4.97. The market value of their outstanding shares is at $1.0 billion. The company's, Q2 earnings came out today.
  • Universe Pharmaceuticals (NASDAQ:UPC) shares rose 11.44% to $4.09. The market value of their outstanding shares is at $52.9 million.
  • Tactile Systems Tech (NASDAQ:TCMD) stock increased by 7.97% to $10.7. The market value of their outstanding shares is at $224.3 million. As per the press release, Q2 earnings came out today.
  • Ultragenyx Pharmaceutical (NASDAQ:RARE) shares rose 6.71% to $30.37. The company's market cap stands at $2.6 billion.

Losers

  • Agilon Health (NYSE:AGL) stock fell 34.0% to $1.2 during Monday's after-market session. The market value of their outstanding shares is at $703.7 million.
  • Inspire Medical Systems (NYSE:INSP) shares decreased by 19.21% to $104.99. The market value of their outstanding shares is at $3.7 billion. As per the press release, Q2 earnings came out today.
  • Longeveron (NASDAQ:LGVN) shares fell 16.62% to $1.43. The market value of their outstanding shares is at $24.5 million.
  • Vertex Pharmaceuticals (NASDAQ:VRTX) shares declined by 14.67% to $403.0. The company's market cap stands at $118.6 billion. As per the press release, Q2 earnings came out today.
  • Hims & Hers Health (NYSE:HIMS) shares fell 12.0% to $55.75. The market value of their outstanding shares is at $14.0 billion. As per the news, the Q2 earnings report came out today.
  • BioXcel Therapeutics (NASDAQ:BTAI) stock fell 8.65% to $2.32. The company's market cap stands at $8.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADAP AGL ARDX BTAI CSTL HIMS INSP LGVN RARE TCMD UPC VRTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist